Minerva Neurosciences, Inc.
NERV
$4.73
-$0.01-0.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -415.07M | -293.42M | -14.03M | 11.23M | 6.25M |
| Total Depreciation and Amortization | 4.20K | 5.60K | 5.60K | 5.60K | 5.60K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 4.30K | 10.70K |
| Total Other Non-Cash Items | 398.18M | 280.54M | 1.12M | -25.43M | -23.08M |
| Change in Net Operating Assets | 2.03M | -632.30K | -1.29M | -1.45M | -715.90K |
| Cash from Operations | -14.87M | -13.51M | -14.20M | -15.63M | -17.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.29M | -- | -- | -- | -- |
| Cash from Investing | -45.29M | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 81.20M | 80.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.67M | -5.55M | -45.20K | -- | -- |
| Cash from Financing | 75.53M | 74.45M | -45.20K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.37M | 60.94M | -14.24M | -15.63M | -17.53M |